(Bloomberg) -- Blood-testing startup Theranos Inc. said it sent doctors andpatients tens of thousands of corrected test results and voided twoyears of data from its devices, a devastating blow for the companythat has come under scrutiny over the accuracy of itstechnology.
The Silicon Valley startup told federal healthregulators at the Centers for Medicare and Medicaid Servicesthat it had voided results from 2014 and 2015 generated by itstesting devices, the Wall Street Journal reported. Theranosspokeswoman Brooke Buchanan confirmed the report by e-mail.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
